Third Affiliated Hospital, Sun Yat-sen University
Clinical trials sponsored by Third Affiliated Hospital, Sun Yat-sen University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tests if ofatumumab can protect nerves in MS patients Results expected Dec 2026 (estimated)
- Can a digital community reverse prediabetes? Results expected Dec 2026 (estimated)
- Can the liver heal itself? new study tracks unexpected recovery in cirrhosis patients Results expected Mar 2027 (estimated)
- Massive hospital study aims to boost hepatitis b diagnosis and treatment Results expected Jun 2027 (estimated)
- Could your own growth factors help heal a spinal cord injury? Results expected Jul 2027 (estimated)
-
New cocktail aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis phase 2 trial tests a combination of low-dose bevacizumab (a blood vessel growth blocker) and adebrelimab (an immunotherapy) along with two liver-directed procedures (TACE and HAIC) as a first treatment for people with unresectable hepatocellular carcinoma, a type of liver c…
Phase 2 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Liver cancer hope: triple therapy shows promise in early trial
Disease control Not yet recruitingThis phase II trial tests a combination of low-dose bevacizumab and atezolizumab (immunotherapy drugs) plus targeted chemotherapy delivered directly to the liver (TACE-HAIC) as a first treatment for people with unresectable hepatocellular carcinoma. About 38 participants will rec…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets unresectable liver cancer
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced liver cancer that cannot be surgically removed. The treatment includes a procedure that delivers chemotherapy directly to the tumor (TACE) plus two drugs that boost the immune system and block blood vessel grow…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could your own growth factors help heal a spinal cord injury?
Disease control Not yet recruitingThis early-phase study tests whether a concentrated form of the patient's own growth factors can improve motor function after a spinal cord injury. Ten adults with moderate to severe traumatic spinal cord injury will receive the treatment. The goal is to see if this approach can …
Early phase 1 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can a digital community reverse prediabetes?
Prevention Not yet recruitingThis study tests whether a virtual health community can help people with prediabetes improve blood sugar control and prevent type 2 diabetes. Participants will receive lifestyle support through a digital platform, including education, guidance, and group interaction. The trial wi…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC